Novel Agent Reduces Bowel Movement Frequency in Carcinoid Syndrome
Irritable bowel syndrome - Wikipedia
JCM, Free Full-Text
Differential diagnosis of diarrhoea in patients with neuroendocrine tumours: A systematic review
Current treatment strategies for patients with advanced gastroenteropancreatic neuroendocrine tumors (GEP-NETs), Clinical Diabetes and Endocrinology
Carcinoid Tumour
Inhibition of Peripheral Synthesis of Serotonin as a New Target in
Management of Diarrhea in Patients With Carcinoid Syndrome. - Abstract - Europe PMC
JCM, Free Full-Text
Recent Advances in the Diagnosis and Management of Carcinoid Syndrome - ScienceDirect
Time to Sustained Improvement in Bowel Movement Frequency with
Safety, tolerability, pharmacokinetics, and pharmacodynamics of a long-acting release (LAR) formulation of pasireotide (SOM230) in patients with gastroenteropancreatic neuroendocrine tumors: results from a randomized, multicenter, open-label, phase I
Complications from carcinoid syndrome: review of the current
Irritable bowel syndrome - Wikipedia
Management of Diarrhea in Patients With Carcinoid Syndrome. - Abstract - Europe PMC